Blockchain Registration Transaction Record
GeoVax to Host Conference Call for First Quarter 2025 Financial Results
GeoVax Labs, Inc. announces conference call to discuss first quarter 2025 financial results and corporate update. Learn about the clinical-stage biotechnology company's innovative vaccines and therapies for COVID-19 and cancer.

This news highlights GeoVax Labs, Inc.'s ongoing efforts in developing innovative vaccines and therapies for critical health issues such as COVID-19 and cancer. The live conference call offers investors and stakeholders an opportunity to gain insights into the company's financial performance and strategic direction, showcasing GeoVax's commitment to advancing healthcare solutions.
Blockchain | Details |
---|---|
Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
Transaction ID | 0xf4f0c1bf24a4edaba4fd5cdcf6ebd16a687a103cea1308e22be926ff70da4709 |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | zestYvTy-8f8655f3ff9fc84a2465a483d5ba1065 |